NeuroKaire
Precision Medicine for Psychiatry and Neurology
StartupNeuroKaire is a Tel Aviv-Yafo-based startup in the Health Tech & Life Sciences sector, established in 2018. Precision Medicine for Psychiatry and Neurology. The company has raised a total of $25.27M across 7 funding rounds, currently at the A stage. NeuroKaire was founded by Talia Cohen Solal and Daphna Laifenfeld. Key investors include GreyBird Ventures, Jumpspeed Ventures, Meron Capital, among 7 total investors. The company has 11-50 employees. Core technologies: Artificial Intelligence, Machine Learning.
With $25.27M in total funding, NeuroKaire is a A-stage company operating in Health Tech & Life Sciences. The company follows a B2B2C/B2B business model. Product stage: Beta. The company holds 1 patent.
- StageA
- ProductBeta
- ModelB2B2C, B2B
- Employees11-50
- HQTel Aviv-Yafo
- DistrictCenter District
- Last Round$10M
- GreyBird VenturesLead
- Jumpspeed Ventures
- Meron Capital
7 investors total
Talia Cohen SolalFounder & CEO
Daphna LaifenfeldFounder & CSO
12 articles covered by sources including www.calcalistech.com,
www.prnewswire.com,
www.medicaldevice-network.com,
www.businesswire.com,
www.prweb.com.
What does NeuroKaire do?
NeuroKaire (formerly Genetika+) is developing a personalized medical testing tool to better treat depression by helping physicians find the best drug therapy for their patients. The NeuroKaire test predicts the best drug treatment for each patient, enabling faster treatment, fewer side effects, and lower dosing.
How much funding has NeuroKaire raised?
NeuroKaire has raised $25.27M in total funding across 7 rounds. The company is currently at the A stage. Key investors include GreyBird Ventures, Jumpspeed Ventures, Meron Capital.
Who founded NeuroKaire ?
NeuroKaire was founded in 2018 by Talia Cohen Solal (Founder & CEO), Daphna Laifenfeld (Founder & CSO).
What sector is NeuroKaire in?
NeuroKaire operates in Health Tech & Life Sciences, Digital Healthcare, Digital Medical Diagnostics, Medical Decision Support, with core technologies in Artificial Intelligence, Machine Learning. Target customers: Healthcare & Life Sciences, Healthcare, Patients, Providers, Life Sciences, Pharmaceuticals.
Where is NeuroKaire located?
NeuroKaire is based in Yigal Alon St 126, Tel Aviv-Yafo, Israel, Center District. The company also has offices abroad.